ABG Sundal Collier Trims ALK-Abelló PT, Keeps Buy Rating

MT Newswires · 2d ago
08:34 AM EDT, 08/17/2026 (MT Newswires) -- ABG Sundal Collier on Monday reduced its price target for specialty pharmaceutical company ALK-Abelló (ALK-B.CO) to 285 Danish kroner from 300 kroner, while maintaining its buy rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)